BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24064359)

  • 1. PPARĪ³ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling.
    Lebovic DI; Kavoussi SK; Lee J; Banu SK; Arosh JA
    Endocrinology; 2013 Dec; 154(12):4803-13. PubMed ID: 24064359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells.
    Arosh JA; Lee J; Starzinski-Powitz A; Banu SK
    Mol Cell Endocrinol; 2015 Jul; 409():51-8. PubMed ID: 25843056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages.
    Makabe T; Koga K; Nagabukuro H; Asada M; Satake E; Taguchi A; Takeuchi A; Miyashita M; Harada M; Hirata T; Hirota Y; Wada-Hiraike O; Fujii T; Osuga Y
    Mol Hum Reprod; 2021 Jan; 27(1):. PubMed ID: 33543288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms.
    Lee J; Banu SK; Burghardt RC; Starzinski-Powitz A; Arosh JA
    Biol Reprod; 2013 Mar; 88(3):77. PubMed ID: 23242524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.
    Banu SK; Lee J; Speights VO; Starzinski-Powitz A; Arosh JA
    Mol Endocrinol; 2009 Aug; 23(8):1291-305. PubMed ID: 19407222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective inhibition of prostaglandin E2 receptors EP2 and EP4 on the miRNA profile in endometriosis.
    Arosh JA; Sivakumar KK; Lee J; Banu SK
    Mol Cell Endocrinol; 2022 Dec; 558():111728. PubMed ID: 35944745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases.
    Lee J; Banu SK; Subbarao T; Starzinski-Powitz A; Arosh JA
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):306-13. PubMed ID: 21111772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.
    Arosh JA; Lee J; Balasubbramanian D; Stanley JA; Long CR; Meagher MW; Osteen KG; Bruner-Tran KL; Burghardt RC; Starzinski-Powitz A; Banu SK
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9716-21. PubMed ID: 26199416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
    Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
    J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective blockade of prostaglandin E2 receptors EP2 and EP4 signaling inhibits proliferation of human endometriotic epithelial cells and stromal cells through distinct cell cycle arrest.
    Lee J; Banu SK; Rodriguez R; Starzinski-Powitz A; Arosh JA
    Fertil Steril; 2010 May; 93(8):2498-506. PubMed ID: 20207353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
    Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis.
    Zeng C; Xu JN; Zhou Y; Yang HX; Zhou YF; Xue Q
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1404-14. PubMed ID: 26394174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin receptor is induced in endometriosis and leptin stimulates the growth of endometriotic epithelial cells through the JAK2/STAT3 and ERK pathways.
    Oh HK; Choi YS; Yang YI; Kim JH; Leung PC; Choi JH
    Mol Hum Reprod; 2013 Mar; 19(3):160-8. PubMed ID: 23184927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.
    Wu Y; Guo SW
    Fertil Steril; 2009 May; 91(5 Suppl):2142-7. PubMed ID: 18571164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early pregnancy induced expression of prostaglandin E2 receptors EP2 and EP4 in the ovine endometrium and regulated by interferon tau through multiple cell signaling pathways.
    Lee J; Banu SK; Nithy TK; Stanley JA; Arosh JA
    Mol Cell Endocrinol; 2012 Jan; 348(1):211-23. PubMed ID: 21907262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
    Lyles BE; Akinyeke TO; Moss PE; Stewart LV
    Cell Cycle; 2009 Jan; 8(2):268-77. PubMed ID: 19164938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms.
    Banu SK; Lee J; Speights VO; Starzinski-Powitz A; Arosh JA
    Endocrinology; 2008 Mar; 149(3):1180-9. PubMed ID: 18039779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor.
    Gras D; Chanez P; Urbach V; Vachier I; Godard P; Bonnans C
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L970-8. PubMed ID: 19346435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARĪ³ agonists target aromatase via both PGE2 and BRCA1.
    Margalit O; Wang D; Dubois RN
    Cancer Prev Res (Phila); 2012 Oct; 5(10):1169-72. PubMed ID: 23041473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.
    Zeitoun K; Takayama K; Michael MD; Bulun SE
    Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.